IV ketamine clinic marketing and Spravato marketing look like the same job from the outside, and they are not. The split comes down to regulatory status. Spravato (esketamine) is FDA-approved for treatment-resistant depression and billed through insurance, while ketamine given by infusion for depression is used off-label and almost always paid for in cash. That single difference changes who your patient is, what you are allowed to say in an ad, which keywords are worth buying, how you present price, and where your referrals come from. Marketing an IV ketamine clinic is a cash-pay consumer acquisition problem. Marketing Spravato is an eligibility and referral problem. Run the same playbook for both and one of them will quietly underperform.
This guide walks through where the two diverge, channel by channel, with search data from the US market and the compliance limits that shape what you can actually run. It is written for clinic owners and the people who market for them. It is educational, not legal or clinical advice.
The difference that drives every other difference
Ketamine has been FDA-approved as an anesthetic for decades. It has never been approved for depression in any formulation. When a clinic gives IV ketamine for treatment-resistant depression, that is legal off-label prescribing by a licensed physician, and it is common practice, but it sits outside the FDA label. Esketamine, sold as Spravato, went the other way. It was approved in March 2019 for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior. In January 2025 the FDA approved it as a monotherapy for TRD, so it no longer has to be paired with a new daily oral antidepressant.
Approval brings insurance coverage. It also brings the Spravato REMS program, which requires the healthcare setting, the prescriber and the patient to be enrolled before a first dose, requires at least two hours of on-site monitoring after each administration, and forbids the drug from leaving the clinic. Every one of those operational facts becomes a marketing constraint.
| Factor | IV ketamine | Spravato (esketamine) |
|---|---|---|
| FDA status for depression | Off-label | Approved for TRD and for MDD with acute suicidal ideation |
| Who pays | Patient, cash-pay in most markets | Commercial insurance, Medicare and many Medicaid plans |
| Gate to treatment | Willingness and ability to pay | Documented failure of two or more antidepressants, plus prior authorization |
| Site requirements | State licensing, clinical protocols | REMS-certified setting, enrolled prescriber, enrolled patient |
| Time on site | Roughly 40 to 90 minutes plus recovery | At least two hours of monitoring after every dose |
| Travel | Patient needs a ride home | Patient needs a ride home, twice weekly at induction |
| Marketing job | Create demand and justify price | Qualify eligibility and win referrals |
| Main risk in ad copy | Efficacy claims about an off-label use | Promoting a branded prescription drug |
Two different patients, two different journeys
The IV ketamine patient usually finds you themselves. They have read about ketamine online, often through a friend, a podcast or a news story, and they arrive curious and a little wary. They may have no formal TRD diagnosis. They are frequently comparing you against at-home ketamine telehealth companies that charge a fraction of what you do. Price is the first question they ask, and if your site does not answer it they call someone whose site does.
The Spravato patient is more often sent. A psychiatrist, primary care physician or therapist raises it after two or more medications have not worked. They arrive with a diagnosis, a medication history and a specific question about coverage. Their hesitation is rarely about price and almost always about the word ketamine, the two-hour monitoring window and whether they will feel strange afterwards. They are also more tired than the average inquiry, because by definition they have already failed a course of treatment.
Those are two different funnels. One is closer to a considered consumer purchase. The other looks like specialty referral medicine. Any agency that hands you one strategy for both has not looked at the economics.
Compliance and advertising restrictions
Both treatments sit in restricted advertising territory, but for different reasons, and the practical consequences are not the same.
Platform certification
Google, Meta and Microsoft treat drug and alcohol treatment as a restricted category and require LegitScript certification to advertise in it. Ketamine services get swept into that category regularly, sometimes correctly and sometimes not, and disapprovals often arrive with no useful explanation. Certification takes documentation and time, and there is no shortcut around it. Budget for the application before you budget for clicks.
What you can say
For IV ketamine the exposure is efficacy language. Because the use is off-label, strong claims about outcomes and remission rates invite scrutiny from the FTC, from state medical boards and from plaintiffs’ attorneys. Describe what you do, who it may be appropriate for and what the evidence base currently supports. Avoid cure language, avoid success percentages you cannot source to your own audited data, and avoid before-and-after emotional testimony that reads as a guarantee.
For Spravato the exposure runs the other way. You are talking about a branded, FDA-approved prescription drug with an approved label and a boxed warning. Practices are not the manufacturer and are not bound by pharmaceutical promotional rules in the same way, but describing the drug in ways that conflict with its label, or implying it treats conditions it is not approved for, is a real risk. Sticking close to the label and to the REMS facts is both safer and more persuasive, because those facts are reassuring.
The rest of the compliance stack
- Tracking pixels and analytics that pass identifiable data about a mental health inquiry need a HIPAA review. This applies to both services and catches most clinics off guard.
- Third-party trademarks. Spravato is a registered mark owned by its manufacturer. Use it accurately, do not restyle the logo, and do not imply endorsement.
- Reviews and testimonials. Patient stories in mental health carry consent and privacy obligations well beyond a standard business review request.
- Compounded ketamine products sold for home use have drawn FDA safety communications. If you do not offer them, say so plainly, because patients are confusing the categories.
SEO strategy: the search volume gap
This is where most of the strategic difference shows up in data. Below are US monthly search volumes and average cost per click for representative terms in each category.
| Keyword | US monthly searches | Average CPC |
|---|---|---|
| spravato | 60,500 | $21.06 |
| spravato treatment | 14,800 | $21.60 |
| what is ketamine therapy | 12,100 | $7.10 |
| ketamine therapy for depression | 6,600 | $12.37 |
| intravenous ketamine therapy | 3,600 | $11.21 |
| spravato side effects | 2,400 | $19.40 |
| spravato near me | 1,900 | $20.14 |
| spravato vs iv ketamine | 50 | $6.04 |
Two things jump out. First, Spravato has strong national brand search but very thin local intent. Sixty thousand searches a month for the brand name sounds enormous until you remember most of it is people researching side effects, cost and experiences, and a large share of those clicks go to the manufacturer’s own site and to Reddit. The term that actually signals a bookable patient, spravato near me, runs at 1,900 a month across the entire country. Split that across every metro in the US and your local slice is small.
Second, Spravato clicks cost roughly twice what ketamine therapy clicks cost. Around $20 against $11. You are paying premium prices for a smaller pool of searchers.
The strategic reading is straightforward. For IV ketamine, organic search can carry real volume, because the top-of-funnel questions people ask before they are ready to book are numerous and answerable. For Spravato, search alone will not fill a schedule in most markets. You still need the pages, because the people searching are extremely high intent, but treat them as a capture layer rather than a growth engine. We break the rest of that channel mix down in our guide to Spravato clinic marketing.
How the page sets differ
- IV ketamine: a treatment page, a conditions page for each indication you treat, an honest pricing page, a comparison page against at-home ketamine, and a steady stream of question-led articles. Volume is available if you go after it.
- Spravato: a treatment page, an insurance and coverage page, a what-to-expect page covering the two-hour window, a candidacy page explaining the two-failed-medications criterion, and a page for referring providers. Fewer pages, each doing more work.
- Both: a single comparison page that explains the difference to patients. It ranks, it answers the question people actually have, and it routes each reader to the right service.
The fundamentals underneath both are the same, and we cover them in our SEO checklist for healthcare providers.
Google Ads
Paid search works for IV ketamine because demand already exists and the transaction is a cash sale you control. You can bid on condition terms, treatment terms and competitor terms, send traffic to a page with a clear price, and measure cost per booked consultation cleanly. The margin supports a meaningful cost per acquisition.
Paid search for Spravato is harder, and it is worth being blunt about why. The brand-name local searches are few, they cost around $20 a click, and the searcher may still turn out to be ineligible or out of network. Chasing scale by widening into broad terms like depression treatment or psychiatrist near me makes the problem worse, because you buy expensive clicks from people who want talk therapy or a medication review.
The version that works is narrow and unglamorous. Bid on the brand term and its close variants inside your drive-time radius. Say insurance accepted in the ad copy, because that is the single most useful qualifier you can put in front of this audience. Cap the budget deliberately, accept that the campaign will be small, and judge it on booked and qualified patients rather than on clicks. Our guide to Google Ads for TMS clinics covers the same structure for the other insurance-covered interventional service, and the logic carries across.
Meta and demand creation
Because Spravato search volume is capped, social is where additional volume comes from. Nobody scrolling Instagram is looking for a psychiatrist, which is exactly why it works: you are introducing the treatment to people who qualify but have never heard of it. Provider-led video explaining what the session involves tends to outperform designed graphics, because the anxiety being answered is about safety and strangeness, not about features.
For IV ketamine, social plays a different role. Demand is already there, so social is mostly about trust and differentiation against cheaper at-home options. Show the room, the staff and the monitoring. The implicit argument is that a medical setting is worth paying for, and that argument is made visually more than verbally. Neither service benefits from the tone that works for aesthetics or wellness marketing, which is a mistake we see often enough to flag in our notes on social media for a medical practice.
Local SEO and the drive-time problem
Both treatments are bounded by geography, and Spravato is bounded harder. A patient in induction comes in twice a week, stays at least two hours after each dose and cannot drive home. That is a serious logistical commitment, and it collapses your realistic catchment to a radius people will actually keep driving for over several weeks.
There is one asset Spravato clinics have that ketamine clinics do not. REMS-certified sites are listed in the official Spravato treatment center locator, and both patients and referring clinicians use it. Confirming and correcting that listing costs nothing and sits entirely outside platform ad restrictions. If you do one thing this week, make it that.
After that, the work is the same for both: a complete and active Google Business Profile, consistent details across directories, and location pages that are genuinely about the location rather than the same paragraph with the suburb name swapped. We go deeper on this in local SEO for psychiatry clinics.
Website messaging and landing pages
Both audiences arrive carrying the same cultural baggage about the word ketamine, and both need the page to defuse it early. What they need next is different.
| Page element | IV ketamine page | Spravato page |
|---|---|---|
| Headline job | Establish this is a medical clinic, not a wellness lounge | Establish this is FDA-approved and covered |
| Money | Price per infusion and per series, stated openly | Insurance accepted, plus how verification works |
| Eligibility | Conditions treated and who is not a candidate | The two-failed-medications criterion in plain words |
| Logistics | Session length, recovery, ride home | Two-hour monitoring, what the room looks like, ride home, visit frequency |
| Primary action | Book a consultation | Check coverage or request a callback |
| Secondary action | Read the pricing page | Refer a patient, for clinicians |
One detail worth more than it looks: photograph your actual observation area. Patients considering Spravato are picturing a hospital bay. Showing a comfortable chair, a window and a blanket answers a question they will not ask out loud.
Conversion and intake
For IV ketamine, conversion is a pricing and confidence exercise. Publish the price. Clinics that hide it lose inquiries to clinics that do not, and the ones who do call spend the first three minutes of the conversation on cost anyway. Offer a short paid or free consultation as the entry point rather than pushing straight to a full series.
For Spravato, conversion is a qualification exercise, and it happens before anyone books. If your intake does not screen for insurance and medication history early, your front desk spends its week on people who cannot proceed. A short structured form that asks about current plan and previous antidepressants, written gently, does more for margin than any change to ad copy. Then move fast: benefits verification and prior authorization take time, and a patient in this position loses momentum quickly.
Referral marketing, where the gap is widest
For IV ketamine, referrals are useful. For Spravato, referrals are the business. Because eligibility depends on a documented history of failed antidepressant trials, the person holding that record is a prescriber, and that prescriber decides whether your clinic ever gets mentioned.
Referral development for Spravato is unglamorous and it compounds. Make it easy to send someone: one page, one form, one phone number, a named person who answers. Tell referrers exactly who qualifies so they stop guessing. Close the loop with a note when a patient starts and when they finish induction, within what privacy rules allow. A psychiatrist who sends one patient and hears nothing back does not send a second.
The referral logic is close to what we describe in patient acquisition for TMS clinics, for the same reason: both are insurance-covered interventional treatments that a generalist has to think of before a patient ever hears the name.
Reputation management
Reviews matter for both, and the risk profile differs. IV ketamine attracts price-related reviews and comparisons against cheaper alternatives. Spravato attracts reviews about the two-hour wait, scheduling and billing, because those are the parts of the experience patients have opinions about. Setting expectations before the first visit prevents more bad reviews than any response template does.
Asking for reviews in mental health takes more care than in most fields. We wrote a full piece on getting Google reviews without breaking HIPAA, and the short version is that you can ask, provided you never confirm publicly that a reviewer is a patient.
Lead nurturing
IV ketamine inquiries usually decide within days to a few weeks, and the blocker is money. Nurture accordingly: a clear breakdown of what a series costs, financing options if you have them, and an answer to the at-home comparison.
Spravato inquiries take longer and the blockers are administrative. Nurture is mostly reassurance and status updates: where the authorization stands, what happens next, what the first visit involves. The patient is not deciding whether to buy, they are waiting on a system, and silence in that window reads as abandonment.
If you offer both
Plenty of clinics run IV ketamine and Spravato side by side, and the combination is a genuine advantage when the marketing reflects it. A few rules that hold up:
- Separate service pages. Merging them confuses patients about coverage and buries both in search.
- One comparison page that sends people to the right door, written for patients rather than for clinicians.
- Separate ad accounts or at minimum separate campaigns, because the cost per click and the acceptable cost per patient are not comparable.
- One intake path that asks about insurance early, so eligible patients get routed to Spravato rather than quoted a cash price they do not need to pay.
- Different success metrics. Cost per booked consultation for ketamine, cost per qualified and authorized patient for Spravato.
Where to start
If you are launching or resetting either program, this is the order that wastes the least money.
- Fix the listings. Google Business Profile for both, and the official Spravato center locator if you are certified.
- Build the right service page, with price for ketamine and coverage for Spravato.
- Start LegitScript certification if you intend to run paid ads at all.
- Open two or three referral conversations for Spravato before spending anything on media.
- Turn on a small, tightly targeted search campaign for ketamine, where paid works best.
- Add social video once you have a page worth sending traffic to.
Frequently asked questions
Is ketamine therapy FDA-approved?
Ketamine is FDA-approved as an anesthetic, not as a treatment for depression. Its use for depression is off-label. Spravato, which contains esketamine, is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior.
Can you run Google Ads for a ketamine clinic?
Usually yes, once you are certified. Ketamine services frequently fall into the restricted drug and alcohol treatment category, which requires LegitScript certification before Google or Meta will run your ads. Without it, expect disapprovals regardless of how the ad is written.
Which is cheaper to market, IV ketamine or Spravato?
Spravato clicks cost more, at roughly $20 against $11 for ketamine therapy terms, and the searchable audience is smaller. But Spravato patients are covered by insurance and stay in treatment longer, so cost per click is a poor comparison on its own. Judge each on cost per completed course of treatment.
Should a clinic that offers both put them on one page?
No. Give each its own service page and add a third page comparing them. Coverage, eligibility and price differ enough that a combined page leaves patients unsure which one applies to them.
How long before Spravato marketing produces patients?
Listings and referral relationships can produce inquiries within weeks. Local rankings take longer, usually a few quarters. Add authorization time on top, so the gap between first inquiry and first dose is often longer than clinic owners expect.
Do referrals matter more than advertising?
For Spravato, yes, in most markets. Eligibility depends on records a prescriber holds, so referral relationships tend to produce more qualified patients than paid media does. For IV ketamine the balance is closer, and paid channels can carry a larger share.
The clinics that grow both services are the ones that stop treating them as one line item. If you want help splitting the strategy properly, that is what CuraReach does for ketamine clinics and Spravato clinics. Book a call and we will look at your market, your coverage mix and where the money is currently going.
